Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Patient profiling for treatment toxicity: potential use of clinical and genomic factors.

Current oncology reports - 1 Feb 2011

Armstrong Terri S, Gilbert Mark R

Abstract excerpt

Significant advances have been made in the identification of genes associated with the occurrence and prognosis of a variety of cancers. Recent efforts have also identified specific genomic single nucleotide polymorphisms (SNPs) that are associated with treatment toxicity in oncology, including t...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Cost-Benefit Analysis
Share to Genome, Human

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasms

Share to Polymorphism, Single Nucleotide

Share to Prognosis

Share to Treatment Outcome

Source

Identifiers

PMID: 21080116
DOI: 10.1007/s11912-010-0141-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-21080116-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Patient profiling for treatment toxicity: potential use of clinical and genomic factors.PMID 21080116Read ↗

Clinical and pharmacogenetic factors associated with irinotecan toxicitySemantic proximity Read ↗

Cancer pharmacogenomics: DNA genotyping and gene expression profiling to identify molecular determinants of chemosensitivity.Semantic proximity Read ↗

Role of genomics in identifying new targets for cancer therapy.Semantic proximity Read ↗

Genetic determinants of cancer drug efficacy and toxicity: practical considerations and perspectives.Semantic proximity Read ↗

TPMT, UGT1A1 and DPYD: genotyping to ensure safer cancer therapy?Semantic proximity Read ↗

Pharmacogenetics in cancer chemotherapy: balancing toxicity and response.Semantic proximity Read ↗

Pharmacogenetic approach for cancer treatment-tailored medicine in practice.Semantic proximity Read ↗

From Genes to Personalized Cancer Care: A Systematic Review of Toxicity-Associated Genetic Variants in Solid Tumor TreatmentsSemantic proximity Read ↗

Toward individualized treatment: prediction of anticancer drug disposition and toxicity with pharmacogeneticsSemantic proximity Read ↗

Pharmacogenetics of irinotecan toxicitySemantic proximity Read ↗

Single nucleotide polymorphisms of ABCC5 and ABCG1 transporter genes correlate to irinotecan-associated gastrointestinal toxicity in colorectal cancer patients: a DMET microarray profiling study.Semantic proximity Read ↗

Precision Medicine: UGT1A1 Genotyping to Better Manage Irinotecan-Induced Toxicity.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.